Literature DB >> 20137600

[Meta-analysis of unicompartmental knee arthroplasty versus high tibial osteotomy in the treatment of unicompartmental knee osteoarthritis].

Qi-Dong Zhang1, Wan-Shou Guo, Zhao-Hui Liu, Qian Zhang, Li-Ming Cheng, Zi-Rong Li.   

Abstract

OBJECTIVE: To assess the efficacy of UKA versus HTO in the treatment of unicompartmental knee osteoarthritis.
METHODS: Comparative studies of UKA and HTO were retrieved from the domestic and foreign literatures and included for a meta-analysis.
RESULTS: Seven eligible randomized controlled trials included 196 UKAs and 219 HTOs. The result of Meta-analysis indicated that the ratio for an excellent outcome was higher in UKA than HTO. The combined OR was 2.43, 95%CI (1.46, 4.05) (P = 0.0006). The risks of revision and complications were lower in UKA than HTO. The combined OR was 0.47 and 0.24 and 95%CI (0.23, 0.97), (0.10, 0.56).
CONCLUSION: UKA reduces the risk of postoperative revision and complications and provides excellent outcomes.

Entities:  

Mesh:

Year:  2009        PMID: 20137600

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Za Zhi        ISSN: 0376-2491


  3 in total

Review 1.  Unicompartmental Knee Osteoarthritis (UKOA): Unicompartmental Knee Arthroplasty (UKA) or High Tibial Osteotomy (HTO)?

Authors:  E Carlos Rodriguez-Merchan
Journal:  Arch Bone Jt Surg       Date:  2016-10

2.  Unicompartmental knee arthroplasty is associated with lower pain levels but inferior range of motion, compared with high tibial osteotomy: a systematic overview of meta-analyses.

Authors:  Hangyu Ping; Jiaxin Wen; Yubo Liu; Haifeng Li; Xin Wang; Xiangpeng Kong; Wei Chai
Journal:  J Orthop Surg Res       Date:  2022-09-24       Impact factor: 2.677

3.  UNICOMPARTMENTAL KNEE ARTHROPLASTY: CURRENT PERSPECTIVES AND TRENDS IN BRAZIL.

Authors:  Gustavo Gonçalves Arliani; João Alberto Yazigi Júnior; Felipe Bertelli Angelini; Fernando Ferlin; Andrea Canizares Hernandes; Diego da Costa Astur; Moises Cohen
Journal:  Rev Bras Ortop       Date:  2015-11-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.